Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine vs Efavirenz in HIV/TB Co-infection
NCT01805258Phase 3Completed
- Sponsor
- AIIMS New Delhi
- Start
- Jun 2007
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nevirapine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Virological suppression at 48 weeks. Started Jun 2007; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01805258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805258.